Expression of human cytochrome p450 3A4 gene in Schizosaccharomyces pombe

被引:0
|
作者
Bedia Palabiyik
Semian Karaer
Nazli Arda
Sidika Erturk Toker
Guler Temizkan
Steven Kelly
Aysegul Topal Sarikaya
机构
[1] Istanbul University,Faculty of Science, Department of Molecular Biology and Genetics
[2] Istanbul University,Faculty of Pharmacy, Department of Analytical Chemistry
[3] Swansea University,School of Medicine, Singleton Park Swansea
来源
Biologia | 2008年 / 63卷
关键词
heterologous expression; cytochrome P450 3A4; P450;
D O I
暂无
中图分类号
学科分类号
摘要
Heterologous expression systems can be utilized to great advantage in the study of cytochrome P450 enzymes. P450 3A4 is one of the major forms of cytochrome P450 found in liver. It is also involved in the metabolism of numerous widely used drugs and xenobiotics. In the present study human liver cytochrome P450 3A4 gene was transferred into the fission yeast Schizosaccharomyces pombe via two different S. pombe expression vectors carrying thiamine repressible promoter — nmt1 (pREP42) and constitutive promoter — adh1 (pART1). Heterologously expressed cytochrome P450 3A4 was detected in the cells grown in minimal (EMM) or rich medium (YEL) containing 0.5% (w/v) glucose. A typical cytochrome P450 peak for 3A4 was observed at 448 nm in microsomal fraction. The presence of heterologous expression of 3A4 form was also determined by SDS-PAGE and it molecular mass was identified as 52 kDa. The enzyme activity was confirmed by HPLC analysis, using testosterone as substrate.
引用
收藏
页码:450 / 454
页数:4
相关论文
共 50 条
  • [1] Expression of human cytochrome p450 3A4 gene in Schizosaccharomyces pombe
    Palabiyik, Bedia
    Karaer, Semian
    Arda, Nazli
    Toker, Sidika Erturk
    Temizkan, Guler
    Kelly, Steven
    Sarikaya, Aysegul Topal
    BIOLOGIA, 2008, 63 (03) : 450 - 454
  • [2] Inhibition of Human Cytochrome P450 3A4 by Cholesterol
    Shinkyo, Raku
    Guengerich, F. Peter
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 18426 - 18433
  • [3] Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase
    Ducharme, Julie
    Sevrioukova, Irina F.
    Thibodeaux, Christopher J.
    Auclair, Karine
    BIOCHEMISTRY, 2021, 60 (28) : 2259 - 2271
  • [4] Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
    Iribarne, C
    Dreano, Y
    Bardou, LG
    Menez, JF
    Berthou, F
    TOXICOLOGY, 1997, 117 (01) : 13 - 23
  • [5] Bacterial expression, purification, and characterization of human cytochrome P450 3A4 without N-terminal modifications
    Sun, Yudong
    Osawa, Yoichi
    Zhang, Haoming
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 762
  • [6] Metabolic Intermediate Complex Formation of Human Cytochrome P450 3A4 by Lapatinib
    Takakusa, Hideo
    Wahlin, Michelle D.
    Zhao, Chunsheng
    Hanson, Kelsey L.
    New, Lee Sun
    Chan, Eric Chun Yong
    Nelson, Sidney D.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (06) : 1022 - 1030
  • [7] Approaches for increasing the electrocatalitic efficiency of cytochrome P450 3A4
    Shumyantseva, Victoria V.
    Koroleva, Polina I.
    Bulko, Tatiana, V
    Shkel, Tatyana, V
    Gilep, Andrei A.
    Veselovsky, Alexander V.
    BIOELECTROCHEMISTRY, 2023, 149
  • [8] N-Heterocyclic Carbene Capture by Cytochrome P450 3A4
    Jennings, Gareth K.
    Ritchie, Caroline M.
    Shock, Lisa S.
    Lyons, Charles E.
    Hackett, John C.
    MOLECULAR PHARMACOLOGY, 2016, 90 (01) : 42 - 51
  • [9] High-throughput fluorescence assay of cytochrome P450 3A4
    Cheng, Qian
    Sohl, Christal D.
    Guengerich, F. Peter
    NATURE PROTOCOLS, 2009, 4 (09) : 1258 - 1261
  • [10] Mechanism-Based Inactivation of Cytochrome P450 3A4 by Benzbromarone
    Tang, Lloyd Wei Tat
    Verma, Ravi Kumar
    Fan, Hao
    Chan, Eric Chun Yong
    MOLECULAR PHARMACOLOGY, 2021, 99 (04) : 266 - 276